Eurofins Pharma Bioanalytical Services announced it will extend its laboratory services to provide consulting to clients to who require expertise and experience in conducting large molecule preclinical and clinical studies.
Eurofins Pharma Bioanalytical Services consulting program will provide expert guidance on bioanalytical assay development and fit-for-purpose assay validation, including troubleshooting for ongoing large molecule bioanalytical assay projects. Company experts can also provide pre-qualification audits ensuring that bioanalytical methods, processes and data quality meet the guidance for regulatory submission.
"Our key strength is our technical expertise, particularly in the large molecule GLP testing space, extending across a diverse type of analytical platforms. Our capabilities are also supported by our quality and regulatory expertise with over 15 years of experience in this specific area of testing services. We are dedicated to meet the needs of customers with an emphasis on the design of large molecule bioanalytical programs," said Christina Shasserre, Senior Vice President Eurofins Pharma Discovery and Bioanalytical Services. "With our extensive scientific, technical and regulatory expertise in conducting studies in both the US and EU, and coupled with our global presence; our consulting team is uniquely qualified to provide our clients with reliability they can trust."
Eurofins Pharma Bioanalytical Services can enable the development of a comprehensive bioanalytical program for large molecule drug development needs.